Venrock Healthcare Capital Partners III L.P. 13D and 13G filings for Dianthus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:47 pm Purchase |
2024-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH |
Venrock Healthcare Capital Partners III L.P. | 1,744,373 5.900% |
816,667 (+88.03%) |
Filing |
| 2023-09-21 4:15 pm Purchase |
2023-09-11 | 13G | Dianthus Therapeutics, Inc. DNTH |
Venrock Healthcare Capital Partners III L.P. | 927,706 6.300% |
927,706 (New Position) |
Filing |